Neurofurans (NeuroFs) and dihomo‐isofurans (dihomo‐IsoFs) are produced in vivo by non‐enzymatic free‐radical pathways from docosahexaenoic and adrenic acids, respectively. As these metabolites are produced in minute amounts, their analyses in biological samples remain challenging. Syntheses of neurofuran and dihomo‐isofurans described are based on a pivotal strategy, thanks to an enantiomerically enriched
神经
呋喃(NeuroFs)和二高异
呋喃(dihomo-IsoFs)分别是通过
二十二碳六烯酸和肾上腺酸的非酶促自由基途径体内产生的。由于这些代谢物的产生量很小,因此在
生物样品中进行分析仍然具有挑战性。所描述的神经
呋喃和二高异
呋喃的合成是基于关键策略的,这要归功于对映异构体富集的中间体,该中间体首次允许同时进入两个家族:烯基和烯二醇。由于这种形成,可以实现对
生物样品中特定NeuroF和dihomo-IsoF的定量。